180 Life Sciences P/E
What is the P/E of 180 Life Sciences?
The P/E of 180 Life Sciences Corp. is 0.53
What is the definition of P/E?
Price to earnings ratio is the ratio of a company’s stock price to the company’s earnings per share calculated over trailing twelve months.
= previous day’s close / ttm EPS
The price to earnings ratio is the most widely used method for determining whether shares are accurately valued in relation to one another. But the P/E ratio does not in itself indicate whether the share is a bargain. The P/E ratio depends on the market’s perception of the risk and future growth in earnings. A company with a low P/E ratio indicates that the market perceives it as a higher risk or a lower growth or both as compared to a company with a higher price to earnings ratio. The P/E ratio of a listed company’s stock is the result of the collective perception of the market as to how risky the company is and what its earnings growth prospects are in relation to that of other companies. Investors use the P/E ratio to compare their own perception of the risk and growth of a company against the market’s collective perception of the risk and growth as reflected in the current P/E ratio.
P/E of companies in the Health Care sector on NASDAQ compared to 180 Life Sciences
What does 180 Life Sciences do?
180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of novel drugs for unmet medical needs in chronic pain, inflammation, inflammatory diseases, and fibrosis. Its product development platforms in Phase IIb/III clinical trials include Fibrosis and anti-tumour necrosis factor (Anti-TNF) platform, which focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are man-made derivatives of CBD; and a7nAChR platform, which focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.
Companies with p/e similar to 180 Life Sciences
- QuantumScape has P/E of 0.52
- Eastnine AB (publ) has P/E of 0.52
- CNFinance Ltd has P/E of 0.52
- China Metal Resources Utilization has P/E of 0.52
- Datametrex AI has P/E of 0.52
- Warehouses De Pauw NV has P/E of 0.53
- 180 Life Sciences has P/E of 0.53
- Salzgitter AG has P/E of 0.53
- Euromedis e has P/E of 0.53
- Star Equity has P/E of 0.54
- AMTD IDEA has P/E of 0.55
- Prairie Provident Resources has P/E of 0.55
- Brighthouse has P/E of 0.55